Mesenchymal stem cell-based TRAIL delivery inhibits the metastatic state of clinical therapy-resistant progressive neuroblastoma

World J Pediatr. 2024 Mar;20(3):287-293. doi: 10.1007/s12519-023-00769-9. Epub 2023 Dec 7.
No abstract available

Publication types

  • Letter

MeSH terms

  • Apoptosis
  • Humans
  • Mesenchymal Stem Cells*
  • Neuroblastoma* / drug therapy
  • Neuroblastoma* / pathology